当归芍药散加味联合达英-35治疗多囊卵巢综合征临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.75

基金项目:


Clinical Study on Modified Danggui Shaoyao Powder Combined with Daying- 35 for Polycystic Ovary Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察当归芍药散加味联合达英-35 治疗肾虚血瘀型多囊卵巢综合征(PCOS) 的疗效及对血 清性激素结合球蛋白(SHBG)、促肾上腺皮质激素(ACTH) 水平的影响。方法:选取92 例肾虚血瘀型PCOS 患者为研究对象,按随机数字表法分为西药组及联合组各46 例,西药组给予达英-35 治疗,联合组予以当归 芍药散加味联合达英-35 治疗,2 组均治疗3 个疗程。比较2 组临床疗效及不良反应发生情况,比较2 组治疗 前后中医证候积分、卵巢体积、子宫内膜厚度、子宫内膜磷脂酰肌醇3 激酶(PI3K)、蛋白激酶B(Akt)、磷 酸化Akt(p-Akt) 蛋白表达及血清SHBG、ACTH 水平的变化。结果:联合组总有效率为93.48%,西药组总 有效率为78.26%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组月经周期、月经量、腰膝酸软或腰 脊刺痛、头晕耳鸣、经行腹痛中医证候积分及总分均较治疗前下降(P<0.05),联合组上述5 项中医证候积分 及总分均低于西药组(P<0.05)。治疗后,2 组两侧卵巢体积均较治疗前下降,子宫内膜厚度均较治疗前上 升,差异均有统计学意义(P<0.05);治疗后,联合组两侧卵巢体积均小于西药组,子宫内膜厚度大于西药 组,差异均有统计学意义(P<0.05)。治疗后,2 组子宫内膜PI3K、Akt、p-Akt 蛋白相对表达量均较治疗前 升高(P<0.05),联合组均高于西药组(P<0.05)。治疗后,2 组血清SHBG 水平均较治疗前升高,ACTH 水 平均较治疗前下降,差异均有统计学意义(P<0.05);治疗后,联合组SHBG 水平高于西药组,ACTH 水平低 于西药组,差异均有统计学意义(P<0.05)。联合组不良反应发生率为4.35%,西药组为13.04%,2 组比较, 差异无统计学意义(P>0.05)。结论:当归芍药散加味联合达英-35 治疗肾虚血瘀型PCOS 疗效显著,能通过 调控PI3K/AKT 信号通路调节生殖轴,缓解患者临床症状,纠正性激素紊乱。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of modified Danggui Shaoyao Powder combined with Daying-35 (Ethinylestradiol and Cyproterone Tablets) on polycystic ovary syndrome (PCOS) of kidney deficiency and blood stasis type and its effect on levels of serum sex hormone- binding globulin (SHBG) and adrenocorticotropic hormone (ACTH). Methods: A total of 92 PCOS patients of kidney deficiency and blood stasis type were selected as research objects and divided into the western medicine group and the combination group according to random number table method,with 46 cases in each group. The western medicine group was treated with Daying- 35, and the combination group was treated with modified Danggui Shaoyao Powder combined with Daying- 35. Both groups were treated for 3 courses of treatment. The clinical effects and the occurrence of adverse reactions were compared between the two groups. The changes of traditional Chinese medicine (TCM) syndrome scores,ovarian volume,endometrial thickness,endometrial protein expressions of phosphatidylinositol 3 kinase (PI3K),protein kinase B (Akt), phosphorylated Akt (p- Akt) and serum SHBG and ACTH levels before and after treatment were compared between the two groups. Results: The total effective rate was 93.48% in the combination group and 78.26% in the western medicine group, the difference being significant (P<0.05). After treatment, the TCM syndrome scores of menstrual cycle, menstrual blood volumn, sore and weak lumbar and knee or lumbar spine trickling,dizziness and tinnitus,and abdominal pain during menstruation and the total scores in the two groups were all decreased when compared with those before treatment (P<0.05), and the above TCM syndrome scores and the total score in the combination group were lower than those in the western medicine group (P<0.05). After treatment, the bilateral ovarian volume was decreased and endometrial thickness was increased in both groups when respectively compared with before treatment, differences being significant (P<0.05). After treatment, the bilateral ovarian volume in the combination group was smaller than that in the western medicine group,and the endometrial thickness was bigger than that in the western medicine group,differences being significant (P<0.05). After treatment,the relative protein expression levels of PI3K, Akt and P- Akt in the endometrium of the two groups were increased when compared with those before treatment (P<0.05),and those in the combination group were higher than those in the western medicine group (P<0.05). After treatment,the serum SHBG levels in the two groups were increased when compared with those before treatment,and the ACTH levels were decreased when compared with those before treatment,differences being significant (P<0.05). After treatment,the SHBG level in the combination group was higher than that in the western medicine group,and the ACTH level was lower than that in the western medicine group, differences being significant (P<0.05). The incidence of adverse reactions was 4.35% in the combination group and 13.04% in the western medicine group,there being no significant difference between the two groups (P>0.05). Conclusion:The therapy of modified Danggui Shaoyao Powder combined with Daying- 35 has a significant therapeutic effect on the treatment of PCOS of kidney deficiency and blood stasis type,which can alleviate clinical symptoms and correct sex hormone disorders by regulating PI3K/AKT signaling pathway and regulating reproductive axis.

    参考文献
    相似文献
    引证文献
引用本文

张杰,李丽娟,刘亚楠.当归芍药散加味联合达英-35治疗多囊卵巢综合征临床研究[J].新中医,2023,55(4):9-12

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-24
  • 出版日期:
文章二维码